Arbitrary Lagrangian-Eulerian Finite Element Modelling of the
... impulses, the rate of which is controlled by the autonomic nervous system. By contracting and expanding periodically the function of the heart is to pump blood through the body circulation system. The pumping capacity is around ve litres per minute for an average adult human and can go up to 35 lit ...
... impulses, the rate of which is controlled by the autonomic nervous system. By contracting and expanding periodically the function of the heart is to pump blood through the body circulation system. The pumping capacity is around ve litres per minute for an average adult human and can go up to 35 lit ...
Cardiac Monitoring & ADHD - Scioto County Medical Society
... • Tachycardia- increase in HR ~ 1-2 bpm • BP- increase in systolic and diastolic BP ~ 3-4 mmHg • No study has demonstrated a significant change in QT or QTc intervals (exception: imipramine, TCAs- rarely used in ADHD) • Because the risk of sudden death in the population of patients pharmacologically ...
... • Tachycardia- increase in HR ~ 1-2 bpm • BP- increase in systolic and diastolic BP ~ 3-4 mmHg • No study has demonstrated a significant change in QT or QTc intervals (exception: imipramine, TCAs- rarely used in ADHD) • Because the risk of sudden death in the population of patients pharmacologically ...
Eplerenone in Patients with Systolic Heart Failure
... spironolactone to recommended therapy in patients with systolic heart failure and moderateto-severe symptoms (i.e., New York Heart Association [NYHA] functional class III or IV symptoms) decreased the rate of death from any cause and the risk of hospitalization for cardiovascular reasons. In the Epl ...
... spironolactone to recommended therapy in patients with systolic heart failure and moderateto-severe symptoms (i.e., New York Heart Association [NYHA] functional class III or IV symptoms) decreased the rate of death from any cause and the risk of hospitalization for cardiovascular reasons. In the Epl ...
CHRONOBIOLOGICAL RHYTHMS IN ONSET H
... acute massive PE was a massive systemic arterial hypotension (SBP ≤90 mmHg)4. Other signs and symptoms that helped in the diagnosis of massive PE included: dyspnea of sudden onset, syncope or near-syncope, tachypnea, right-sided heart failure, cyanosis, clinical signs of organ hypoperfusion and hypo ...
... acute massive PE was a massive systemic arterial hypotension (SBP ≤90 mmHg)4. Other signs and symptoms that helped in the diagnosis of massive PE included: dyspnea of sudden onset, syncope or near-syncope, tachypnea, right-sided heart failure, cyanosis, clinical signs of organ hypoperfusion and hypo ...
Incidence and type of cardiac arrhythmias in critically ill patients: a
... before admission to our ICU and sinus tachycardia were excluded. All patients had continuous electrocardiographic monitoring, and all arrhythmias were recorded automatically, including electrocardiography, date and time (Arrhythmia Display/Controller ADC, Hewlett and Packard, Andover, Mass., USA). T ...
... before admission to our ICU and sinus tachycardia were excluded. All patients had continuous electrocardiographic monitoring, and all arrhythmias were recorded automatically, including electrocardiography, date and time (Arrhythmia Display/Controller ADC, Hewlett and Packard, Andover, Mass., USA). T ...
12 HEART RATE VARIABILITY FOR ASSESSING STRESS IN
... ACTH (0.5 μg/kg) increased (P<0.05) serum cortisol concentrations in cows within 30 min of administration, and concentrations remained increased (P<0.05) throughout the blood sampling period (120 min). Doses of ACTH have varied from 0.125, 0.25, 0.50, or 1 IU of ACTH per kilogram of BW (body weight) ...
... ACTH (0.5 μg/kg) increased (P<0.05) serum cortisol concentrations in cows within 30 min of administration, and concentrations remained increased (P<0.05) throughout the blood sampling period (120 min). Doses of ACTH have varied from 0.125, 0.25, 0.50, or 1 IU of ACTH per kilogram of BW (body weight) ...
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
... investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment. This r ...
... investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment. This r ...
Congenitally corrected transposition
... onset depend on the associated malformations, with bradycardia, a single loud second heart sound and a heart murmur being the most common manifestations. In the rare cases where there are no associated malformations, congenitally corrected transposition can lead to progressive atrioventricular valva ...
... onset depend on the associated malformations, with bradycardia, a single loud second heart sound and a heart murmur being the most common manifestations. In the rare cases where there are no associated malformations, congenitally corrected transposition can lead to progressive atrioventricular valva ...
Acute heart failure
... A randomised controlled trial should be conducted to investigate whether the addition of low-dose dopamine to standard therapy leads to more clinically and cost effective decongestion in people admitted to hospital for treatment of decompensated heart failure. The study should aim to investigate the ...
... A randomised controlled trial should be conducted to investigate whether the addition of low-dose dopamine to standard therapy leads to more clinically and cost effective decongestion in people admitted to hospital for treatment of decompensated heart failure. The study should aim to investigate the ...
Drug-Induced QT Prolongation
... led to numerous advances in our understanding of how drugs produce QT prolongation.1 Torsades de Pointes (TdP) is a concern in any patient receiving a drug with QT prolonging potential. TdP is a polymorphic ventricular arrhythmia which may result from LQTS and can lead to cardiac arrest. At least ni ...
... led to numerous advances in our understanding of how drugs produce QT prolongation.1 Torsades de Pointes (TdP) is a concern in any patient receiving a drug with QT prolonging potential. TdP is a polymorphic ventricular arrhythmia which may result from LQTS and can lead to cardiac arrest. At least ni ...
Heart Rate Variability Training - Biofeedback Federation of Europe
... rate predicts a greater risk for death after a heart attack and death from all causes in adults, especially sudden death. Studies have also shown that clinical depression lowers heart rate variability. What is the relationship between Heart Rate Variability and Biofeedback? Heart Rate Variability Bi ...
... rate predicts a greater risk for death after a heart attack and death from all causes in adults, especially sudden death. Studies have also shown that clinical depression lowers heart rate variability. What is the relationship between Heart Rate Variability and Biofeedback? Heart Rate Variability Bi ...
Influences of Physical Training on the Heart of Dogs
... Received February 4, 1974. Accepted for publication August 27, 1974. Circulation Research, VoL 35, December 197i ...
... Received February 4, 1974. Accepted for publication August 27, 1974. Circulation Research, VoL 35, December 197i ...
Document
... renal arterioles. It exerts its pharmacological effect through the activation of purine A1 and A2 cell-surface adenosine receptors - Half-life 4-10 seconds ...
... renal arterioles. It exerts its pharmacological effect through the activation of purine A1 and A2 cell-surface adenosine receptors - Half-life 4-10 seconds ...
How We Do CMR Perfusion
... renal arterioles. It exerts its pharmacological effect through the activation of purine A1 and A2 cell-surface adenosine receptors - Half-life 4-10 seconds ...
... renal arterioles. It exerts its pharmacological effect through the activation of purine A1 and A2 cell-surface adenosine receptors - Half-life 4-10 seconds ...
Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in
... Despite evidence that myocardial hypertrophy and fibrosis are mediated by angiotensin II and are important determinants of morbidity and mortality in patients with HCM, no prior studies have evaluated the effects of angiotensin receptor blockers on LV hypertrophy and fibrosis with cardiac magnetic res ...
... Despite evidence that myocardial hypertrophy and fibrosis are mediated by angiotensin II and are important determinants of morbidity and mortality in patients with HCM, no prior studies have evaluated the effects of angiotensin receptor blockers on LV hypertrophy and fibrosis with cardiac magnetic res ...
Heart failure with preserved ejection fraction: Clinical
... mean (SD) LVEF was 59 (9)% and almost 80% of patients were in NYHA Class III or IV. Approximately 80% of patients were also overweight or obese. Heart failure was reported by investigators to have a hypertensive aetiology in 64% of patients. Prior myocardial infarction was relatively uncommon (24%), ...
... mean (SD) LVEF was 59 (9)% and almost 80% of patients were in NYHA Class III or IV. Approximately 80% of patients were also overweight or obese. Heart failure was reported by investigators to have a hypertensive aetiology in 64% of patients. Prior myocardial infarction was relatively uncommon (24%), ...
This educational slide module includes notes and diagrams of slides
... values must be individualized for each patient. ...
... values must be individualized for each patient. ...
Does this patient have CHF - Division of General Internal Medicine
... An a priori decision was made to exclude studies that investigated other cardiac neurohormones such as A-type natriuretic peptide or other forms of BNP (eg, NT-proBNP). It was thought at the time of this review that there would be insufficient published data on these other neurohormones to draw sign ...
... An a priori decision was made to exclude studies that investigated other cardiac neurohormones such as A-type natriuretic peptide or other forms of BNP (eg, NT-proBNP). It was thought at the time of this review that there would be insufficient published data on these other neurohormones to draw sign ...
Atrial Fibrillation - the University Health Network
... calcium blockers, and Digoxin. These drugs work by slowing down electrical impulses through the AV node, thereby slowing down the heart rate. This allows the ventricles to pump blood at a slower, more appropriate rate. Your atria, however, will still experience A-Fib and be fibrillating, so blood-th ...
... calcium blockers, and Digoxin. These drugs work by slowing down electrical impulses through the AV node, thereby slowing down the heart rate. This allows the ventricles to pump blood at a slower, more appropriate rate. Your atria, however, will still experience A-Fib and be fibrillating, so blood-th ...
Failure to precondition pathological human myocardium
... earlier shown, also in the rat heart, that myocardial infarction is reduced in diabetes and that PC further increases the protection of these hearts. There are very few studies in human diabetic tissue. Cleveland et al. (16) used a functional isolated atrial trabeculae model and showed that PC did n ...
... earlier shown, also in the rat heart, that myocardial infarction is reduced in diabetes and that PC further increases the protection of these hearts. There are very few studies in human diabetic tissue. Cleveland et al. (16) used a functional isolated atrial trabeculae model and showed that PC did n ...
Radiofrequency Catheter Ablation of Premature Ventricular
... group) according to the tertiles of %PVC. Baseline characteristics of the patients are shown in Table 1. There was no statistical difference in body surface area, hemodynamic variables including systolic and diastolic blood pressure and resting heart rate, or the prevalence of diabetes (7%, 8%, and ...
... group) according to the tertiles of %PVC. Baseline characteristics of the patients are shown in Table 1. There was no statistical difference in body surface area, hemodynamic variables including systolic and diastolic blood pressure and resting heart rate, or the prevalence of diabetes (7%, 8%, and ...
Hypertrophic Cardiomyopathy
... • Define Cardiomyopathy • Cardiomyopathy Functional Classifications: – Dilated Cardiomyopathy – Hypertrophic Cardiomyopathy – Restrictive Cardiomyopathy – Arrhythmogenic Right Ventricular Cardiomyopathy • Underwriting Cardiomyopathy • Case Studies ...
... • Define Cardiomyopathy • Cardiomyopathy Functional Classifications: – Dilated Cardiomyopathy – Hypertrophic Cardiomyopathy – Restrictive Cardiomyopathy – Arrhythmogenic Right Ventricular Cardiomyopathy • Underwriting Cardiomyopathy • Case Studies ...
Diastolic Heart Failure After Cardiac Surgery
... decreased cardiac output and hypotension (Pinsky , 2005 2007)]. Pericardial constriction or tamponade causes increased resistance to diastolic filling and physiologically is “acute severe extrinsic diastolic failure” whereby the heart becomes physically compressed by the pericardial effusion. Renal ...
... decreased cardiac output and hypotension (Pinsky , 2005 2007)]. Pericardial constriction or tamponade causes increased resistance to diastolic filling and physiologically is “acute severe extrinsic diastolic failure” whereby the heart becomes physically compressed by the pericardial effusion. Renal ...
Form for submission of comments
... endpoints, some of these without a clear relationship with a change in prognosis and in most cases affected by several cofounding factors in the context of a clinical trial. For e.g. heart rate might be one of these parameters. In addition to the comment above, it would be of interest in designing a ...
... endpoints, some of these without a clear relationship with a change in prognosis and in most cases affected by several cofounding factors in the context of a clinical trial. For e.g. heart rate might be one of these parameters. In addition to the comment above, it would be of interest in designing a ...
Coronary artery disease
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), atherosclerotic heart disease, atherosclerotic cardiovascular disease, and coronary heart disease, is a group of diseases that includes: stable angina, unstable angina, myocardial infarction, and sudden coronary death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and gets better with rest. Shortness of breath may also occur and sometimes no symptoms are present. The first sign is occasionally a heart attack. Other complications include heart failure or an irregular heartbeat.Risk factors include: high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol, among others. Other risks include depression. The underlying mechanism involves atherosclerosis of the arteries of the heart. A number of tests may help with diagnoses including: electrocardiogram, cardiac stress testing, coronary computed tomographic angiography, and coronary angiogram, among others.Prevention is by eating a healthy diet, regular exercise, maintaining a healthy weight and not smoking. Sometimes medication for diabetes, high cholesterol, or high blood pressure are also used. There is limited evidence for screening people who are at low risk and do not have symptoms. Treatment involves the same measures as prevention. Additional medications such as antiplatelets including aspirin, beta blockers, or nitroglycerin may be recommended. Procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) may be used in severe disease. In those with stable CAD it is unclear if PCI or CABG in addition to the other treatments improve life expectancy or decreases heart attack risk.In 2013 CAD was the most common cause of death globally, resulting in 8.14 million deaths (16.8%) up from 5.74 million deaths (12%) in 1990. The risk of death from CAD for a given age has decreased between 1980 and 2010 especially in the developed world. The number of cases of CAD for a given age has also decreased between 1990 and 2010. In the United States in 2010 about 20% of those over 65 had CAD, while it was present in 7% of those 45 to 64, and 1.3% of those 18 to 45. Rates are higher among men than women of a given age.